← Eichor
Condition: Pericarditis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pericarditis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Phase 2 · 2 location(s) · University of Cape Town · NCT04521803CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome
Phase N/A · 10 location(s) · Meyer Children's Hospital IRCCS · NCT07468461CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Phase 3 · 27 location(s) · Cardiol Therapeutics Inc. · NCT06708299Transition to KPL-387 Monotherapy Dosing & Administration Study
Phase 2 · 39 location(s) · Kiniksa Pharmaceuticals International, plc · NCT07288216COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
Phase N/A · 1 location(s) · Ottawa Heart Institute Research Corporation · NCT05046002An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
Phase 2 · 18 location(s) · Zomagen Biosciences Ltd. · NCT06836232EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07077304Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
Phase 2/Phase 3 · 58 location(s) · Kiniksa Pharmaceuticals International, plc · NCT07010159Genomics and COVID-19 Vaccine Adverse Events
Phase N/A · 1 location(s) · University of British Columbia · NCT05212792Multimodal Analysis of Endomyocardial Biopsies
Phase N/A · 1 location(s) · University Hospital, Essen · NCT07359690Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels
Phase N/A · 9 location(s) · ASST Fatebenefratelli Sacco · NCT05925790
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.